Bakuchi for Skin Health

Moderate evidence 8 studies

Research suggests that Bakuchi (Psoralea corylifolia) and its active compounds — particularly psoralen, bakuchiol, and bakuchicin — have been studied for a range of skin health applications, with the strongest and most consistent body of evidence centered on vitiligo and leukoderma, conditions characterized by loss of skin pigmentation. The available literature consists primarily of reviews and systematic reviews from 2019 to 2024, with no randomized controlled trials included in this set, and the overall direction of findings is supportive of traditional use rather than conclusive proof of clinical efficacy. Studies indicate that psoralens from Bakuchi have a long history in both Ayurvedic and traditional Chinese medicine for depigmentation disorders, while bakuchiol has drawn more recent scientific interest for broader dermatological applications including hyperpigmentation and general skin health benefits. The absence of clinical trial data in this collection is a meaningful limitation, and readers should note that the existing evidence largely reflects traditional documentation, pharmacological characterization, and narrative review rather than rigorous experimental testing in human populations.

Related studies

Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.

Title Type Year Direction Match
Phytochemical and Pharmacological Aspects of Psoralen - A Bioactive Furanocou... Review 2023 Supports 95
Psoralea corylifolia L.: a comprehensive review of its botany, traditional us... Review 2023 Supports 90
Isolation, Cytotoxicity, and In-silico Screening of Coumarins from Psoralea c... Other 2024 Supports 85
Genus Psoralea: A review of the traditional and modern uses, phytochemistry a... Systematic review 2019 Supports 85
The Use of Bakuchiol in Dermatology: A Review of In Vitro and In Vivo Evidence. Review 2022 Supports 78
Applications of bakuchiol in dermatology: Systematic review of the literature. Systematic review 2022 Supports 75
Bakuchicin attenuates atopic skin inflammation. Other 2020 Supports 65
Psoralea corylifolia L. and its active component isobavachalcone demonstrate ... Other 2024 Neutral 60

← Back to Bakuchi

Medical Disclaimer: Noyemi provides information from published research for educational purposes only. This content is not medical advice and does not replace consultation with a qualified healthcare provider. Always consult your doctor before starting, stopping, or changing any supplement regimen, especially if you take medications or have existing health conditions.